4//SEC Filing
Glenn Jeffrey S 4
Accession 0001209191-18-020459
CIK 0001305253other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 8:26 PM ET
Size
5.4 KB
Accession
0001209191-18-020459
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-03-14+10,000→ 10,000 totalExercise: $9.50Exp: 2028-03-13→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 12 months measured from March 14, 2018 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001670382
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 8:26 PM ET
- Size
- 5.4 KB